超性心肌病综述:遗传学,查和治疗
1Department of Surgery, Michigan State University College of Human Medicine, East Lansing, MI.
概括
增高性心肌病 (HCM) 是一种遗传性心脏病,导致心脏壁变厚. 早期基因检测和查对于管理突发心脏病死亡等风险和改善患者寿命至关重要.
科学领域:
- 心脏病学 心脏病学
- 遗传学 是一个遗传学.
- 内部医学 内部医学
背景情况:
- 增高性心肌病变 (HCM) 是一种普遍存在的遗传心脏疾病,其特征是无法解释的不对称的左心室壁加厚.
- 组织病理学标志包括心肌细胞增大和纤维化,导致腹功能障碍和潜在的流出管道阻塞.
研究的目的:
- 概述超性心肌病的理解,诊断和管理.
- 强调基因分析和家庭查在识别风险人群中的重要性.
主要方法:
- 审查目前对HCM病理生理学和遗传基础的理解.
- 讨论包括心电图,心声图和心脏MRI在内的诊断工具.
- 治疗策略的概述,包括药物和干预措施.
主要成果:
- HCM源于sarcomere蛋白的突变,具有突发心脏病死亡的风险,特别是在年轻人中.
- 随着遗传鉴定,查和监测协议取得了重大进展.
- 早期诊断和有针对性的干预措施改善了患者的治疗结果和寿命.
结论:
- 及时诊断HCM是关键的,因为它与心脏突然死亡和有效治疗的可用性有关.
- 基因分析和家族查对于临床前载体的综合管理和鉴定至关重要.
- 了解HCM的进步改善了管理,为受影响个体提供了更长,更健康的生活的潜力.
相关概念视频
Pathophysiology of Heart Failure
1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
Pulmonary Hypertension: Classification and Pathogenesis
142
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
142
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
126
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
126
Ischemic Heart Disease: Overview
1.1K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.1K
Hypertension and Regulation of Blood Pressure
1.9K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
1.9K
Genome-wide Association Studies-GWAS
12.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.3K


